Outcomes of Percutaneous Endoscopic Gastrostomy (PEG) Feeding in Parkinson’s
Objective: To describe outcomes of PEG feeding in Parkinson's and related disorders. Background: PEG feeding provides a means of getting food, liquid and medication safely…Gastrointestinal symptoms predict cognitive decline in Parkinson’s Disease
Objective: To explore the predictive value of non-motor symptoms on the cognitive decline of patients with Parkinson’s disease (PD) in a three-year follow up. Background:…Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms
Objective: This study was to compare zonisamide and other anti-PD drugs by analyzing their associations with the incidence of PD-relevant symptoms. Background: Patients with Parkinson’s…Evaluation of gut microbiota in patients with Parkinson’s disease using a gas chromatography–mass spectrometry in Russia
Objective: To evaluat of gut microbiota in patients with Parkinson's disease using a gas chromatography–mass spectrometry Background: An increasing number of studies have reported the…Gut Feelings about Parkinson’s Disease: The Influence of the Gut Microbiota in a Rodent Model
Objective: The objective of this study was to investigate the gut microbiota in a pilot cohort of Australian patients with PD, and a rodent model…Gastrointestinal disorders in various forms of parkinsonism
Objective: To examine the types of gastrointestinal disorders in parkinsonism, depending on the form of the disease. Background: One of the non-motor autonomic disorders of…Effect of Levodopa on gut microbiome in Parkinson’s Disease (PD)
Objective: To characterize changes in the gut microbiome in de novo PD subjects before and after initiating carbidopa/levodopa Background: The gastrointestinal microbiome in patients with…GASTROPARK: Multicenter study on the efficacy of dopamine agonists for gastrointestinal symptoms in Parkinson’s disease
Objective: Main: To assess the modification of gastrointestinal symptoms in patients with Parkinson's disease before and after the introduction of dopamine agonists. Secondary: (1) To…Clinical characteristics of turkish patients with Parkinson’s disease: A retrospective analysis of 428 patients
Objective: To evaluate the demographic, motor and non-motor clinical characteristics of Turkish Parkinson’s disease (PD) patients in our Movement Disorders Outpatient Clinic. Background: Although PD…Weight variation in Parkinson’s disease patients treated with levodopa-carbidopa intestinal gel infusion
Objective: To compare weight variations between three cohorts of patients with advanced Parkinson’s disease (PD): patients during their first year of treatment either with levodopa-carbidopa…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- Next Page »